Lumosa Therapeutics , Ltd. Profit Margin

Lumosa Therapeutics , Ltd.'s profit margin stands at -1076.78% as of June 2026. That compares with -1687.45% in the prior-year period — up 36.2% year over year. That is below the Healthcare sector average of 21.34%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Lumosa Therapeutics , Ltd. reported -1076.78% in profit margin versus -1687.45% a year earlier — a 36.2% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Lumosa Therapeutics , Ltd. sits lower the Healthcare benchmark (21.34%) with a profit margin of -1076.78%. That is roughly 5147.0% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -1076.78% for Lumosa Therapeutics , Ltd. means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Lumosa Therapeutics , Ltd.'s profit margin evolved across reporting periods, while the comparison chart places 6535.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.